Xarelto, also known as rivaroxaban, does not currently have an approved generic version available in the United States [1].
When Might a Generic Xarelto Become Available?
The patent for Xarelto is set to expire in 2028 [2]. However, patent expirations do not always directly correlate with the immediate availability of generic versions. Legal challenges and the development and approval process for generics can influence the timeline [3].
What is Xarelto Used For?
Xarelto is an anticoagulant medication, commonly referred to as a blood thinner. It is prescribed to prevent and treat blood clots in adults, reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation [4]. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent these conditions from recurring. Additionally, it is used in certain patients who have had hip or knee replacement surgery to prevent blood clots [4].
How Does Xarelto Work?
Xarelto is a direct factor Xa inhibitor. Factor Xa is a crucial enzyme in the blood clotting cascade. By inhibiting factor Xa, Xarelto prevents the conversion of prothrombin to thrombin, thereby reducing thrombin generation and clot formation [4].
Who Makes Xarelto?
Xarelto is manufactured by Bayer [1].
What Are the Risks Associated with Xarelto?
The primary risk associated with Xarelto, like other anticoagulants, is bleeding. Bleeding can occur in any part of the body and can be serious, even life-threatening [4]. Patients taking Xarelto should be aware of signs of bleeding, such as unusual bruising, nosebleeds, or blood in urine or stool, and seek medical attention if these occur [4].
What Are Alternatives to Xarelto?
Other anticoagulant medications are available, including warfarin (Coumadin), apixaban (Eliquis), and dabigatran (Pradaxa) [5]. These alternatives differ in their mechanisms of action, dosing regimens, monitoring requirements, and potential side effect profiles [5]. The choice of anticoagulant is individualized based on a patient's specific medical condition, risk factors, and other medications [4][5].
What are the Differences Between Xarelto and Eliquis?
Xarelto (rivaroxaban) and Eliquis (apixaban) are both direct oral anticoagulants (DOACs) that inhibit factor Xa. While they share a similar mechanism, they have different chemical structures, dosages, and administration schedules. Eliquis is typically taken twice daily, whereas Xarelto is usually taken once daily [5]. Clinical studies have compared their efficacy and safety, with results indicating similar effectiveness in preventing stroke and systemic embolism and comparable bleeding risks, though specific nuances exist in their safety profiles across different patient populations [5].
What is the Expected Cost of Generic Xarelto?
The cost of generic medications is typically significantly lower than their brand-name counterparts once they become available. However, without an approved generic version of Xarelto, specific pricing information for a generic is not yet applicable [3].
*
**Sources:
1. https://www.drugpatentwatch.com/drug/rivaroxaban
2. https://www.drugpatentwatch.com/drug/rivaroxaban
3. https://www.drugpatentwatch.com/
4. Xarelto Prescribing Information
5. https://www.mayoclinic.org/diseases-conditions/blood-clots/in-depth/blood-clot-prevention/art-20045176